期刊文献+

人类白细胞抗原单倍体相合脐血移植治疗儿童慢性粒细胞白血病一例并文献复习 被引量:1

Human leukocyte antigen haploidentical umbilical cord blood transplantation in the treatment of a child with chronic myeloid leukemia and literature review
原文传递
导出
摘要 目的:探讨人类白细胞抗原(HLA)单倍体相合脐血移植治疗儿童慢性粒细胞白血病(CML)的疗效及可行性。方法报道1例7岁CML患儿,给予白消安(Bu)/环磷酰胺(Cy)联合兔抗人免疫球蛋白(ATG)预处理方案,环孢素(CsA)联合吗替麦考酚酯(MMF)、甲氨蝶呤(MTX)预防移植物抗宿主病(GVHD);行HLA单倍体相合脐血移植。结果患儿中性粒细胞植活时间为移植后10 d,血小板植活时间为移植后30 d,无急、慢性GVHD发生。结论HLA单倍体相合脐血移植可以作为儿童CML的一种选择。
出处 《白血病.淋巴瘤》 CAS 2016年第2期119-121,共3页 Journal of Leukemia & Lymphoma
  • 相关文献

参考文献12

  • 1中国慢性髓系白血病诊断与治疗指南(2011年版)[J].中华血液学杂志,2011,32(6):426-432. 被引量:81
  • 2Druker BJ. Translation of the Philadelphia chromosome into therapyfor CML [J]. Blood, 2009, 112 (13): 4808-4817. DOI:10.1182/blood-2008-07-077958.
  • 3de Lavallade H,Apperley JF,Khorashad JS,et al. Imatinib for newlydiagnosed patients with chronic myeloid leukemia : incidence ofsustained responses in an intention-to-treat analysis [ J ]. J ClinOncol, 2008, 26 (20): 3358-3363. DOI: 10.1200/jc0. 2007.15.8154.
  • 4Khoury HJ,Kukreja M,Goldman JM, et al. Prognostic factors foroutcomes in allogeneic transplantation for CML in the imatinib era: aCIBMTR analysis [ J ]. Bone Marrow Transplant, 2012, 47 ( 6 ):810*816. DOI: 10.1038/bmt.2011.194.
  • 5Shima H, Tokuyama M, Tanizawa A, et al. Distinct impact ofimatinib on growth at repubertal and pubertal ages of children withchronic myeloid leukemia [ J ] . J Pediatr, 2011,159 ( 4 ) : 676-681.D01:10.1016/j.jpeds.2011.03.046.
  • 6Goussetis E,Constantoulakis P, Kitra V, et al. Successful bonemarrow transplantation in a pediatric patient with chronic myeloidleukemia from a HLA-identical sibling selected by preimplantationHLA testing [ J ] . Pediatr Blood Cancer, 2011,57 ( 2 ) : 345-347.D01:10.1002/pbc.23007.
  • 7Eapen M, Rubinstein P, Zhang MJ, et al. Outcomes oftransplantation of unrelated donor umbilical cord blood and bonemarrow in children with acute leukaemia : a comparison study [ J ].Lancet, 2007,369 (9577 ) : 1947-1954. DOI: 10.1016/S0140-6736(07)60915-5.
  • 8Nagamura-Inoue T, Kai S, Azuma H, et al. Unrelated cord bloodtransplantation in CML: Japan Cord Blood Bank Network analysis[J]. Bone Marrow Transplant, 2008,42 ( 4): 241-251. DOI:10.1038/bmt.2008.164.
  • 9Bailen KK, Gluckman E,Broxmeyer HE. Umbilical cord bloodtransplantation: the first 25 years and beyond [ J ]. Blood,2013, 122(4) : 491-498. DOI: 10.1182/blood-2013-02-453175.
  • 10孙自敏.脐血造血干细胞移植的现状[J].中华器官移植杂志,2014,35(1):1-2. 被引量:8

二级参考文献72

  • 1黄河,蔡真,林茂芳,谢万灼,梁彬,李黎,何静松,罗依,郑伟燕,张洁,叶琇锦,胡晓蓉,陈水云,金爱云.非亲缘异基因骨髓移植治疗儿童白血病[J].中华儿科杂志,2004,42(11):835-839. 被引量:7
  • 2贺其图,时风桐,袁祖正.包头市白血病流行病学调查[J].内蒙古医学杂志,1993,13(2):3-5. 被引量:10
  • 3江倩,陈珊珊,江滨,江浩,丘镜滢,刘艳荣,张艳,秦亚溱,陆颖,黄晓军,陆道培.甲磺酸伊马替尼治疗慢性粒细胞白血病慢性期100例追踪观察[J].中华血液学杂志,2006,27(11):721-726. 被引量:39
  • 4O' Brien S, Berman E, Borghaei H, et al. NCCN clinical practice guidelines in oncology: chronic myelogenous leukemia. J Natl Cane Netw, 2009, 7:982-1023.
  • 5NCCN Clinical Practice Guidelines in Oncology (NCCN Guide- lines^TM )-FREE: Chronic Myelogenous Leukemia. Version 2. 2011[ 2011-03-29 ]. http//www. nccn. org/professionals/physi- cian_gls/f_guidelines. asp.
  • 6Baccarani M, Saglio G, Goldman J, et al. Evolving concepts in the management of chronic mycloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood, 2006, 108 : 1809-1820.
  • 7Baccarani M,Cortes J,Pane F, et al. Chronic myeloid leukemia, an update of concepts and management Recommendations of the Euro- peanLeukemiaNet. J Clin Oncol, 2009, 27:6041-6051.
  • 8World Health Organization Classification of Tumors. Pathology and Genetic of Tumors of Haematopoietic and Lymphoid Tissue. 2008.
  • 9Sokal JE, Baccarani M, Russo D, et al. Staging and prognosis in chronic myelogenous leukemia. Semin Hematol, 1988,25:49-61.
  • 10Schiffer CA. BCR-ABL tyrosine kinase inhibitors for chronic my- elogenous leukemia. N Engl J Med, 2007,357:258-265.

共引文献87

同被引文献21

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部